• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by SWK Holdings Corporation (Amendment)

    2/10/23 4:21:40 PM ET
    $SWKH
    Diversified Financial Services
    Finance
    Get the next $SWKH alert in real time by email
    SC 13G/A 1 fp0082186-7_sc13ga.htm

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (Amendment No. 1)

      

    SWK Holdings CorpORATION

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    78501P203

    (CUSIP Number)

     

    December 31, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [   ]Rule 13d-1(b)
    [X]Rule 13d-1(c)
    [   ]Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Continued on following pages)

     

     

    CUSIP NO. 78501P203   13G   Page 2 of 9 Pages

     

    1 NAMES OF REPORTING PERSONS
     
    M3 FUNDS, LLC
     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)    [   ]

    (b)    [   ]

    3 SEC USE ONLY
     
     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
     
    STATE OF DELAWARE, UNITED STATES OF AMERICA
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER
     
    N/A

    6 SHARED VOTING POWER
     
    795,245 shares of Common Stock
    7 SOLE DISPOSITIVE POWER
     
    N/A
    8 SHARED DISPOSITIVE POWER
     
    795,245 shares of Common Stock
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    795,245 shares of Common Stock
     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

     
    [  ]
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    6.20% of the outstanding shares of Common Stock
     
    12 TYPE OF REPORTING PERSON
     
    OO (Limited Liability Company)
     

     

     

    CUSIP NO. 78501P203   13G   Page 3 of 9 Pages

     

    1

    NAMES OF REPORTING PERSONS
     
    M3 PARTNERS, LP

     

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)    [   ]
    (b)    [   ]

    3 SEC USE ONLY
     
     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
     
    STATE OF DELAWARE, UNITED STATES OF AMERICA
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER
     
     N/A

    6 SHARED VOTING POWER
     
    795,245 shares of Common Stock
    7 SOLE DISPOSITIVE POWER
     
    N/A
    8 SHARED DISPOSITIVE POWER
     
    795,245 shares of Common Stock
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    795,245 shares of Common Stock
     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
     

     

    [  ]

     

    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    6.20% of the outstanding shares of Common Stock
     
    12 TYPE OF REPORTING PERSON
     
    PN (Limited Partnership)
     

     

     

    CUSIP NO. 78501P203   13G   Page 4 of 9 Pages

     

    1 NAMES OF REPORTING PERSONS
     
    M3F, INC.
     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)    [   ]
    (b)    [   ]

    3 SEC USE ONLY
     
     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
     
    STATE OF UTAH, UNITED STATES OF AMERICA
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER
     
    N/A

    6 SHARED VOTING POWER
     
    795,245 shares of Common Stock
    7 SOLE DISPOSITIVE POWER
     
    N/A
    8 SHARED DISPOSITIVE POWER
     
    795,245 shares of Common Stock
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    795,245 shares of Common Stock
     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
     
    [  ]
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    6.20% of the outstanding shares of Common Stock
     
    12 TYPE OF REPORTING PERSON
     
    CO, IA
     

     

     

    CUSIP NO. 78501P203   13G   Page 5 of 9 Pages

     

    1 NAMES OF REPORTING PERSONS
     
    Jason A. Stock
     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)    [   ]
    (b)    [   ]

    3 SEC USE ONLY
     
     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
     
    UNITED STATES OF AMERICA
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    5 SOLE VOTING POWER
     
    N/A
    6 SHARED VOTING POWER
     
    795,245 shares of Common Stock
    7 SOLE DISPOSITIVE POWER
     
    N/A
    8 SHARED DISPOSITIVE POWER
     
    795,245 shares of Common Stock
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    795,245 shares of Common Stock
     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

     
    [  ]
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    6.20% of the outstanding Common Stock
     
    12 TYPE OF REPORTING PERSON
     
    IN
     

     

     

    CUSIP NO. 78501P203   13G   Page 6 of 9 Pages

     

    1 NAMES OF REPORTING PERSONS
     
    William C. Waller
     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)    [   ]
    (b)    [   ]

    3 SEC USE ONLY
     
     
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
     
    UNITED STATES OF AMERICA
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH
    5 SOLE VOTING POWER
     
    N/A
    6 SHARED VOTING POWER
     
    795,245 shares of Common Stock
    7 SOLE DISPOSITIVE POWER
     
    N/A
    8 SHARED DISPOSITIVE POWER
     
    795,245 shares of Common Stock
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    795,245 shares of Common Stock
     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
     
    [  ]
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    6.20% of the outstanding Common Stock
     
    12 TYPE OF REPORTING PERSON
     
    IN
     

     

     

    Item 1.(a) Name of Issuer:

     

    SWK Holdings Corporation (the “Issuer”)

     

    (b)Address of Issuer’s Principal Executive Offices:

     

    14755 Preston Road, Suite 105

    Dallas, TX 75254

     

     

    Item 2. (a) Name of Persons Filing:

     

    M3 Funds, LLC

    M3 Partners, LP

    M3F, Inc.

    Jason A. Stock

    William C. Waller

     

    (b)Address of Principal Business Office or, if None, Residence:

     

    For all persons filing:

     

    2070 E 2100 S, Suite 250

    Salt Lake City, UT 84109

     

    (c)Citizenship:

     

    M3 Funds, LLC is a Delaware limited liability company

    M3 Partners, LP is a Delaware limited partnership

    M3F, Inc. is a Utah corporation

    Mr. Stock and Mr. Waller are United States citizens

     

    (d)Title of Class of Securities:

     

    Common Stock

     

    (e)CUSIP Number:

     

    78501P203

     

    Item 3.If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

     

    Not applicable. Filed pursuant to Rule 13d-1(c).

     

     

    Item 4.Ownership.

     

     

    M3 Funds, LLC

    M3 Partners, LP

    M3F, Inc.

    Jason A. Stock

    William C. Waller

    (a) Amount Beneficially Owned: 795,245 795,245 795,245 795,245 795,245
    (b) Percent of Class: 6.20% 6.20% 6.20% 6.20% 6.20%

    (c) Number of Shares to Which Reporting Person Has:

         
    (i) Sole Voting Power: N/A N/A N/A N/A N/A
    (ii) Shared Voting Power: 795,245 795,245 795,245 795,245 795,245
    (iii) Sole Dispositive Power: N/A N/A N/A N/A N/A
    (iv) Shared Dispositive Power: 795,245 795,245 795,245 795,245 795,245

     

    The reported shares are the Issuer’s common stock.

     

    All of the reported shares are owned directly by M3 Partners, L.P. (“M3 Partners”), whose general partner is M3 Funds, LLC (the “General Partner”) and whose investment adviser is M3F, Inc. (the “Investment Adviser”). The General Partner and the Investment Adviser could each be deemed to be indirect beneficial owners of the reported shares, and could be deemed to share such beneficial ownership with M3 Partners.

     

    Jason A. Stock and William C. Waller are the managers of the General Partner and the managing directors of the Investment Adviser, and could be deemed to share such indirect beneficial ownership with the General Partner, the Investment Adviser and M3 Partners.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ].

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not applicable.

     

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below, each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 

     

     

    Signature

     

    After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies that the information set forth in this Statement is true, complete and correct.

     

      Date:

    February 10, 2023

     
           
      M3 PARTNERS, LP  
           
      By: M3 Funds, LLC, General Partner  
           
      By: /s/ Jason A. Stock  
      Name: Jason A. Stock  
      Title: Manager  
           
      Date:

    February 10, 2023

     
           
      M3 FUNDS, LLC  
           
      By: /s/ Jason A. Stock  
      Name: Jason A. Stock  
      Title: Manager  
           
      Date:

    February 10, 2023

     
           
      M3F, INC.  
           
      By: /s/ Jason A. Stock  
      Name: Jason A. Stock  
      Title: Managing Director  
           
      Date: February 10, 2023  
           
      /s/ Jason A. Stock  
      Jason A. Stock  
           
      Date:

    February 10, 2023

     
           
      /s/ William C. Waller  
      William C. Waller  

     

     

    Get the next $SWKH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SWKH

    DatePrice TargetRatingAnalyst
    12/28/2022$26.00Buy
    Lake Street
    4/18/2022$26.00Buy
    Lake Street
    More analyst ratings

    $SWKH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ImpediMed Secures $15m Growth Capital Funding

      New round will help fuel commercialization efforts in support of ImpediMed's platform technology for the detection and monitoring of lymphedema. CARLSBAD, Calif., Feb. 7, 2025 /PRNewswire/ -- ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, today announced an agreement for a five-year $15 million growth capital facility with SWK Holdings (NASDAQ:SWKH), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies. Funds raised will provide ImpediMed with funding flexibility and will be used to support growth and commercialization activities. Armentum Partners acted as the Company's exclusiv

      2/7/25 11:00:00 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

      January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A. Shangold as Chief Medical Officer with immediate effect. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: "I am delighted to welcome Gary to the team. As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists

      1/22/25 8:30:00 AM ET
      $BDRX
      $JNJ
      $SWKH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Diversified Financial Services
      Finance
    • SWK Holdings Provides Portfolio Update

      DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update for material events occurring since September 30, 2024.OriginationsIn November, SWK advanced $5.0M to existing borrower Journey Medical to help fund the company's launch of EmrosiTM.In November, as part of a broader amendment SWK advanced $0.6M to existing borrower Biotricity. On amendment closing, SWK received 600,000 warrants to purchase Biotricity stock at $0.50 per share.In December, SWK closed an $8.0M senior secured term loan with Triple

      1/6/25 7:35:00 AM ET
      $SWKH
      Diversified Financial Services
      Finance

    $SWKH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by SWK Holdings Corporation

      SC 13G/A - SWK Holdings Corp (0001089907) (Subject)

      11/14/24 11:49:47 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Amendment: SEC Form SC 13D/A filed by SWK Holdings Corporation

      SC 13D/A - SWK Holdings Corp (0001089907) (Subject)

      10/25/24 4:05:56 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SEC Form SC 13G/A filed by SWK Holdings Corporation (Amendment)

      SC 13G/A - SWK Holdings Corp (0001089907) (Subject)

      2/14/24 2:14:12 PM ET
      $SWKH
      Diversified Financial Services
      Finance

    $SWKH
    SEC Filings

    See more

    $SWKH
    Leadership Updates

    Live Leadership Updates

    See more

    $SWKH
    Financials

    Live finance-specific insights

    See more

    $SWKH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $SWKH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SWK Holdings Corporation filed SEC Form 8-K: Other Events

      8-K - SWK Holdings Corp (0001089907) (Filer)

      5/19/25 8:47:29 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SWK Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SWK Holdings Corp (0001089907) (Filer)

      5/15/25 4:23:24 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SWK Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SWK Holdings Corp (0001089907) (Filer)

      5/15/25 4:22:48 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

      January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A. Shangold as Chief Medical Officer with immediate effect. Commenting, Stephen Stamp, CEO and CFO of Biodexa said: "I am delighted to welcome Gary to the team. As Biodexa moves towards the later clinical stages including an upcoming global Phase 3 registrational study in FAP, it is essential we access specialists

      1/22/25 8:30:00 AM ET
      $BDRX
      $JNJ
      $SWKH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Diversified Financial Services
      Finance
    • SWK Holdings Appoints Chief Financial Officer

      Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of Adam C. Rice, CPA, as Chief Financial Officer (CFO) of the company and the promotion of Courtney Baker, CPA, to Controller.With over 18 years of senior-level finance and accounting leadership experience, Rice has led financial operations management, corporate financial planning and analysis, strategic planning and financial statement reporting. He was previously CFO of Park Cities Asset Management, an SEC

      7/8/24 5:00:00 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Stanley Black & Decker Appoints Chris Nelson Chief Operating Officer and Executive Vice President and President of Tools & Outdoor

      NEW BRITAIN, Conn., May 2, 2023 /PRNewswire/ -- Stanley Black & Decker (NYSE:SWK) today announced the appointment of Chris Nelson as Chief Operating Officer of the company, and Executive Vice President and President of Tools & Outdoor, effective June 14, 2023. Nelson joins Stanley Black & Decker from Carrier Corporation and brings more than 25 years of leadership experience in general management, product development and innovation, and growth transformation. Nelson will report to Donald Allan Jr., President and CEO of Stanley Black & Decker. He will assume the role of President, Tools & Outdoor, from current Acting Co-Presidents Robert Raff and John Wyatt. Raff will continue to serve as Chie

      5/2/23 4:36:00 PM ET
      $SWK
      $SWKH
      Industrial Machinery/Components
      Consumer Discretionary
      Diversified Financial Services
      Finance
    • SWK Holdings Corporation Announces Financial Results for Third Quarter 2024

      Conference Call Scheduled for Friday, November 15, 2024, at 09:00 a.m. CSTCorporate HighlightsThird quarter 2024 GAAP net income was $3.5 million, compared with GAAP net income of $4.5 million for the third quarter 2023.Third quarter 2024 finance receivables segment adjusted non-GAAP net income was $5.0 million, compared with adjusted non-GAAP net income of $5.8 million for the third quarter 2023.As of September 30, 2024, net finance receivables were $255.9 million, a 14.4% increase from September 30, 2023.The third quarter 2024 effective yield was 14.6%, a 60 basis points increase from third quarter 2023.As of September 30, 2024, GAAP book value per share was $22.94, a 3.7% increase from $2

      11/14/24 4:15:00 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • SWK Holdings Provides Portfolio Update

      Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results

      10/17/24 4:15:00 PM ET
      $BTCY
      $DERM
      $ELUT
      $ETON
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Biotechnology: Biological Products (No Diagnostic Substances)
    • SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

      DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies."During the second quarter we advanced capital to two existing borrowers and are working towards an additional closing in the next month," said SWK President and CEO Jody Staggs."Importantly, several of our borrower partners took advantage of the strong capital markets to raise equity or other forms of non-dilutive financing. We also repurchased $1 million of st

      7/17/24 4:15:00 PM ET
      $BIOL
      $BTCY
      $DERM
      $ELUT
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Biotechnology: Biological Products (No Diagnostic Substances)
    • Lake Street resumed coverage on SWK Holdings with a new price target

      Lake Street resumed coverage of SWK Holdings with a rating of Buy and set a new price target of $26.00

      12/28/22 9:18:49 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Lake Street initiated coverage on SWK Holdings with a new price target

      Lake Street initiated coverage of SWK Holdings with a rating of Buy and set a new price target of $26.00

      4/18/22 8:44:23 AM ET
      $SWKH
      Diversified Financial Services
      Finance
    • PRESIDENT Staggs Joe David Jr exercised 33,750 shares at a strike of $11.22 and covered exercise/tax liability with 25,857 shares, increasing direct ownership by 7% to 123,766 units (SEC Form 4)

      4 - SWK Holdings Corp (0001089907) (Issuer)

      4/17/25 4:34:14 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • PRESIDENT Staggs Joe David Jr was granted 36,700 shares, increasing direct ownership by 46% to 115,873 units (SEC Form 4)

      4 - SWK Holdings Corp (0001089907) (Issuer)

      2/4/25 4:14:55 PM ET
      $SWKH
      Diversified Financial Services
      Finance
    • Chief Financial Officer Rice Adam was granted 9,175 shares, increasing direct ownership by 151% to 15,247 units (SEC Form 4)

      4 - SWK Holdings Corp (0001089907) (Issuer)

      2/4/25 4:14:24 PM ET
      $SWKH
      Diversified Financial Services
      Finance